Mallinckrodt Medical Now Covidien Work Values

Daily Duties at Mallinckrodt Medical Now Covidien:

Provide strategic plans to direct the development for new products and acquisitions globally. Assure cost effectiveness and outcome criteria have been met for all new products. Work with the FDA, CMS, and US Pharmacopeia to create strategies enabling nationwide payment from third party payors for existing and new Mallinckrodt products. Supported sales in excess of $ 950 million and launched a sales campaign generating over $350,000 in revenue in three months through the development of a customer software tool. Received Addis award for direct marketing 1994. Obtained nationwide reimbursement for three new products within 1 year of product launch using comparative effectiveness analysis. Used outcome and cost models generated from discharge data to re-launch an established product to avert discounts. Requested speaker at Medical Forums on Cost Effectiveness and Outcomes. Requested by the International Institute of Research and International Business Communications to provide presentations and workshops on disease state management, developing automated IT methods to track patient outcomes, develop cost effectiveness studies into phase II, III, and IV clinical trials within FDA guidelines. Services Provided to Mallinckrodt Customers. Created a health care financial services group, consistent with Mallinckrodt's strategic plan, which provided consulting to hospitals across the nation regarding revenue enhancement strategies, TQM, CQI, and process re-engineering. Able to support sales in excess of $950 million while operating within a $45,000 advertising budget. Field support of this program required training of 300 sales representatives in four Mallinckrodt product divisions to assist with implementation of the tactical portion of our marketing plan.

What they like about Mallinckrodt Medical Now Covidien:

Working in an organization that is technologically advanced, creative, and innovative is critical in your assessment of hiring companies. Less important to you are stability of the organization, the length of time an organization has been in business, and the business' plans for the future. You prefer a fast-moving company that will take risks to achieve its goals and objectives. The length of time the company has been in business is irrelevant. Maintaining status quo is unnecessary. You thrive on change, uncertainty and the upside of potential business risks, especially those associated with innovation. Stability for the long haul is not nearly as important as is working in an atmosphere that is charged with a sense of urgency and constant change.

Tags

economic analyses, FDA submission, reimbursement, tissue engineering, biomarkers/drug co development, Improve physician decision making

Skills

FDA submission, Obtain Reimbursement from CMS and commercial insurance companies, New product development, Market assessment against portfolio analysis, Presentation on Health Care Economics, Clinical trial design to achieve FDA approval AND reimbursement, Cost effectiveness analysis , Negotiate reimbursement with local payers, Education healhcare providers on new product use, Cross functional team building, Relationship database development, Business analyst to achieve information system improvement, Marketing and Sales

These are some of the questions we asked our climbers about their experiences with Mallinckrodt Medical Now Covidien: